Global Orphan Drugs Market Insights and Forecast to 2026

Global Orphan Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Orphan Drugs Product Introduction
1.2 Market Segments
1.3 Key Orphan Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Orphan Drugs Market Size Growth Rate by Type
1.4.2 Oncology
1.4.3 Gastrointestinal
1.4.4 Pulmonary
1.4.5 Neurology
1.4.6 Hematology
1.4.7 Cardio-vascular
1.4.8 Metabolic disorders
1.4.9 Endocrinology
1.4.10 Infectious diseases
1.4.11 Others
1.5 Market by Application
1.5.1 Global Orphan Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Speciality Pharmacies
1.5.4 Retail pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Orphan Drugs Market Size, Estimates and Forecasts
2.1.1 Global Orphan Drugs Revenue 2015-2026
2.1.2 Global Orphan Drugs Sales 2015-2026
2.2 Global Orphan Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Orphan Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Orphan Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Orphan Drugs Competitor Landscape by Players
3.1 Orphan Drugs Sales by Manufacturers
3.1.1 Orphan Drugs Sales by Manufacturers (2015-2020)
3.1.2 Orphan Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Orphan Drugs Revenue by Manufacturers
3.2.1 Orphan Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Orphan Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Orphan Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Orphan Drugs Revenue in 2019
3.2.5 Global Orphan Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Orphan Drugs Price by Manufacturers
3.4 Orphan Drugs Manufacturing Base Distribution, Product Types
3.4.1 Orphan Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Orphan Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Orphan Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Orphan Drugs Market Size by Type (2015-2020)
4.1.1 Global Orphan Drugs Sales by Type (2015-2020)
4.1.2 Global Orphan Drugs Revenue by Type (2015-2020)
4.1.3 Orphan Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Orphan Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Orphan Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Orphan Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Orphan Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Orphan Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Orphan Drugs Market Size by Application (2015-2020)
5.1.1 Global Orphan Drugs Sales by Application (2015-2020)
5.1.2 Global Orphan Drugs Revenue by Application (2015-2020)
5.1.3 Orphan Drugs Price by Application (2015-2020)
5.2 Orphan Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Orphan Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Orphan Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Orphan Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Orphan Drugs by Country
6.1.1 North America Orphan Drugs Sales by Country
6.1.2 North America Orphan Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Orphan Drugs Market Facts & Figures by Type
6.3 North America Orphan Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Orphan Drugs by Country
7.1.1 Europe Orphan Drugs Sales by Country
7.1.2 Europe Orphan Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Orphan Drugs Market Facts & Figures by Type
7.3 Europe Orphan Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Orphan Drugs by Region
8.1.1 Asia Pacific Orphan Drugs Sales by Region
8.1.2 Asia Pacific Orphan Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Orphan Drugs Market Facts & Figures by Type
8.3 Asia Pacific Orphan Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Orphan Drugs by Country
9.1.1 Latin America Orphan Drugs Sales by Country
9.1.2 Latin America Orphan Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Orphan Drugs Market Facts & Figures by Type
9.3 Central & South America Orphan Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Orphan Drugs by Country
10.1.1 Middle East and Africa Orphan Drugs Sales by Country
10.1.2 Middle East and Africa Orphan Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Orphan Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Orphan Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Description and Business Overview
11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis AG Orphan Drugs Products Offered
11.1.5 Novartis AG Related Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Description and Business Overview
11.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Company Orphan Drugs Products Offered
11.2.5 Bristol-Myers Squibb Company Related Developments
11.3 Celgene Corporation
11.3.1 Celgene Corporation Corporation Information
11.3.2 Celgene Corporation Description and Business Overview
11.3.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Celgene Corporation Orphan Drugs Products Offered
11.3.5 Celgene Corporation Related Developments
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.4.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Ltd. Orphan Drugs Products Offered
11.4.5 F. Hoffmann-La Roche Ltd. Related Developments
11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Corporation Information
11.5.2 Pfizer, Inc. Description and Business Overview
11.5.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer, Inc. Orphan Drugs Products Offered
11.5.5 Pfizer, Inc. Related Developments
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Corporation Information
11.6.2 Sanofi S.A. Description and Business Overview
11.6.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi S.A. Orphan Drugs Products Offered
11.6.5 Sanofi S.A. Related Developments
11.7 Alexion Pharmaceuticals, Inc.
11.7.1 Alexion Pharmaceuticals, Inc. Corporation Information
11.7.2 Alexion Pharmaceuticals, Inc. Description and Business Overview
11.7.3 Alexion Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Alexion Pharmaceuticals, Inc. Orphan Drugs Products Offered
11.7.5 Alexion Pharmaceuticals, Inc. Related Developments
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Corporation Information
11.8.2 Eli Lilly and Company Description and Business Overview
11.8.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Eli Lilly and Company Orphan Drugs Products Offered
11.8.5 Eli Lilly and Company Related Developments
11.9 Novo Nordisk A/S
11.9.1 Novo Nordisk A/S Corporation Information
11.9.2 Novo Nordisk A/S Description and Business Overview
11.9.3 Novo Nordisk A/S Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novo Nordisk A/S Orphan Drugs Products Offered
11.9.5 Novo Nordisk A/S Related Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Description and Business Overview
11.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AstraZeneca Orphan Drugs Products Offered
11.10.5 AstraZeneca Related Developments
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Description and Business Overview
11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis AG Orphan Drugs Products Offered
11.1.5 Novartis AG Related Developments
11.12 Daiichi Sankyo Company Limited
11.12.1 Daiichi Sankyo Company Limited Corporation Information
11.12.2 Daiichi Sankyo Company Limited Description and Business Overview
11.12.3 Daiichi Sankyo Company Limited Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Daiichi Sankyo Company Limited Products Offered
11.12.5 Daiichi Sankyo Company Limited Related Developments
11.13 Bayer AG
11.13.1 Bayer AG Corporation Information
11.13.2 Bayer AG Description and Business Overview
11.13.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Bayer AG Products Offered
11.13.5 Bayer AG Related Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Corporation Information
11.14.2 GlaxoSmithKline Description and Business Overview
11.14.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.14.4 GlaxoSmithKline Products Offered
11.14.5 GlaxoSmithKline Related Developments
11.15 Merck & Co., Inc.
11.15.1 Merck & Co., Inc. Corporation Information
11.15.2 Merck & Co., Inc. Description and Business Overview
11.15.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Merck & Co., Inc. Products Offered
11.15.5 Merck & Co., Inc. Related Developments
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Corporation Information
11.16.2 Johnson & Johnson Description and Business Overview
11.16.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Johnson & Johnson Products Offered
11.16.5 Johnson & Johnson Related Developments
11.17 Biogen, Inc.
11.17.1 Biogen, Inc. Corporation Information
11.17.2 Biogen, Inc. Description and Business Overview
11.17.3 Biogen, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Biogen, Inc. Products Offered
11.17.5 Biogen, Inc. Related Developments
11.18 Takeda
11.18.1 Takeda Corporation Information
11.18.2 Takeda Description and Business Overview
11.18.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Takeda Products Offered
11.18.5 Takeda Related Developments
11.19 Amgen, Inc.
11.19.1 Amgen, Inc. Corporation Information
11.19.2 Amgen, Inc. Description and Business Overview
11.19.3 Amgen, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Amgen, Inc. Products Offered
11.19.5 Amgen, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Orphan Drugs Market Estimates and Projections by Region
12.1.1 Global Orphan Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Orphan Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Orphan Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Orphan Drugs Sales Forecast (2021-2026)
12.2.2 North America: Orphan Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Orphan Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Orphan Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Orphan Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Orphan Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Orphan Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Orphan Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Orphan Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Orphan Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Orphan Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Orphan Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Orphan Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Orphan Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Orphan Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Orphan Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Orphan Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Orphan Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Orphan Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Orphan Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Orphan Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Orphan Drugs Market Segments
Table 2. Ranking of Global Top Orphan Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Orphan Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oncology
Table 5. Major Manufacturers of Gastrointestinal
Table 6. Major Manufacturers of Pulmonary
Table 7. Major Manufacturers of Neurology
Table 8. Major Manufacturers of Hematology
Table 9. Major Manufacturers of Cardio-vascular
Table 10. Major Manufacturers of Metabolic disorders
Table 11. Major Manufacturers of Endocrinology
Table 12. Major Manufacturers of Infectious diseases
Table 13. Major Manufacturers of Others
Table 14. Global Orphan Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 15. Global Orphan Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 16. Global Orphan Drugs Sales by Regions 2015-2020 (K Units)
Table 17. Global Orphan Drugs Sales Market Share by Regions (2015-2020)
Table 18. Global Orphan Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Orphan Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 20. Global Orphan Drugs Sales Share by Manufacturers (2015-2020)
Table 21. Global Orphan Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Orphan Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orphan Drugs as of 2019)
Table 23. Orphan Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Orphan Drugs Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Orphan Drugs Price (2015-2020) (USD/Unit)
Table 26. Orphan Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Orphan Drugs Product Type
Table 28. Date of International Manufacturers Enter into Orphan Drugs Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Orphan Drugs Sales by Type (2015-2020) (K Units)
Table 31. Global Orphan Drugs Sales Share by Type (2015-2020)
Table 32. Global Orphan Drugs Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Orphan Drugs Revenue Share by Type (2015-2020)
Table 34. Orphan Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 35. Global Orphan Drugs Sales by Application (2015-2020) (K Units)
Table 36. Global Orphan Drugs Sales Share by Application (2015-2020)
Table 37. North America Orphan Drugs Sales by Country (2015-2020) (K Units)
Table 38. North America Orphan Drugs Sales Market Share by Country (2015-2020)
Table 39. North America Orphan Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Orphan Drugs Revenue Market Share by Country (2015-2020)
Table 41. North America Orphan Drugs Sales by Type (2015-2020) (K Units)
Table 42. North America Orphan Drugs Sales Market Share by Type (2015-2020)
Table 43. North America Orphan Drugs Sales by Application (2015-2020) (K Units)
Table 44. North America Orphan Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Orphan Drugs Sales by Country (2015-2020) (K Units)
Table 46. Europe Orphan Drugs Sales Market Share by Country (2015-2020)
Table 47. Europe Orphan Drugs Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Orphan Drugs Revenue Market Share by Country (2015-2020)
Table 49. Europe Orphan Drugs Sales by Type (2015-2020) (K Units)
Table 50. Europe Orphan Drugs Sales Market Share by Type (2015-2020)
Table 51. Europe Orphan Drugs Sales by Application (2015-2020) (K Units)
Table 52. Europe Orphan Drugs Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Orphan Drugs Sales by Region (2015-2020) (K Units)
Table 54. Asia Pacific Orphan Drugs Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Orphan Drugs Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Orphan Drugs Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Orphan Drugs Sales by Type (2015-2020) (K Units)
Table 58. Asia Pacific Orphan Drugs Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Orphan Drugs Sales by Application (2015-2020) (K Units)
Table 60. Asia Pacific Orphan Drugs Sales Market Share by Application (2015-2020)
Table 61. Latin America Orphan Drugs Sales by Country (2015-2020) (K Units)
Table 62. Latin America Orphan Drugs Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Orphan Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Orphan Drugs Revenue Market Share by Country (2015-2020)
Table 65. Latin America Orphan Drugs Sales by Type (2015-2020) (K Units)
Table 66. Latin America Orphan Drugs Sales Market Share by Type (2015-2020)
Table 67. Latin America Orphan Drugs Sales by Application (2015-2020) (K Units)
Table 68. Latin America Orphan Drugs Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Orphan Drugs Sales by Country (2015-2020) (K Units)
Table 70. Middle East and Africa Orphan Drugs Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Orphan Drugs Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Orphan Drugs Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Orphan Drugs Sales by Type (2015-2020) (K Units)
Table 74. Middle East and Africa Orphan Drugs Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Orphan Drugs Sales by Application (2015-2020) (K Units)
Table 76. Middle East and Africa Orphan Drugs Sales Market Share by Application (2015-2020)
Table 77. Novartis AG Corporation Information
Table 78. Novartis AG Description and Major Businesses
Table 79. Novartis AG Orphan Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Novartis AG Product
Table 81. Novartis AG Recent Development
Table 82. Bristol-Myers Squibb Company Corporation Information
Table 83. Bristol-Myers Squibb Company Description and Major Businesses
Table 84. Bristol-Myers Squibb Company Orphan Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Bristol-Myers Squibb Company Product
Table 86. Bristol-Myers Squibb Company Recent Development
Table 87. Celgene Corporation Corporation Information
Table 88. Celgene Corporation Description and Major Businesses
Table 89. Celgene Corporation Orphan Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Celgene Corporation Product
Table 91. Celgene Corporation Recent Development
Table 92. F. Hoffmann-La Roche Ltd. Corporation Information
Table 93. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 94. F. Hoffmann-La Roche Ltd. Orphan Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. F. Hoffmann-La Roche Ltd. Product
Table 96. F. Hoffmann-La Roche Ltd. Recent Development
Table 97. Pfizer, Inc. Corporation Information
Table 98. Pfizer, Inc. Description and Major Businesses
Table 99. Pfizer, Inc. Orphan Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Pfizer, Inc. Product
Table 101. Pfizer, Inc. Recent Development
Table 102. Sanofi S.A. Corporation Information
Table 103. Sanofi S.A. Description and Major Businesses
Table 104. Sanofi S.A. Orphan Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Sanofi S.A. Product
Table 106. Sanofi S.A. Recent Development
Table 107. Alexion Pharmaceuticals, Inc. Corporation Information
Table 108. Alexion Pharmaceuticals, Inc. Description and Major Businesses
Table 109. Alexion Pharmaceuticals, Inc. Orphan Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Alexion Pharmaceuticals, Inc. Product
Table 111. Alexion Pharmaceuticals, Inc. Recent Development
Table 112. Eli Lilly and Company Corporation Information
Table 113. Eli Lilly and Company Description and Major Businesses
Table 114. Eli Lilly and Company Orphan Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Eli Lilly and Company Product
Table 116. Eli Lilly and Company Recent Development
Table 117. Novo Nordisk A/S Corporation Information
Table 118. Novo Nordisk A/S Description and Major Businesses
Table 119. Novo Nordisk A/S Orphan Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Novo Nordisk A/S Product
Table 121. Novo Nordisk A/S Recent Development
Table 122. AstraZeneca Corporation Information
Table 123. AstraZeneca Description and Major Businesses
Table 124. AstraZeneca Orphan Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. AstraZeneca Product
Table 126. AstraZeneca Recent Development
Table 127. Eisai Co., Ltd. Corporation Information
Table 128. Eisai Co., Ltd. Description and Major Businesses
Table 129. Eisai Co., Ltd. Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Eisai Co., Ltd. Product
Table 131. Eisai Co., Ltd. Recent Development
Table 132. Daiichi Sankyo Company Limited Corporation Information
Table 133. Daiichi Sankyo Company Limited Description and Major Businesses
Table 134. Daiichi Sankyo Company Limited Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 135. Daiichi Sankyo Company Limited Product
Table 136. Daiichi Sankyo Company Limited Recent Development
Table 137. Bayer AG Corporation Information
Table 138. Bayer AG Description and Major Businesses
Table 139. Bayer AG Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 140. Bayer AG Product
Table 141. Bayer AG Recent Development
Table 142. GlaxoSmithKline Corporation Information
Table 143. GlaxoSmithKline Description and Major Businesses
Table 144. GlaxoSmithKline Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 145. GlaxoSmithKline Product
Table 146. GlaxoSmithKline Recent Development
Table 147. Merck & Co., Inc. Corporation Information
Table 148. Merck & Co., Inc. Description and Major Businesses
Table 149. Merck & Co., Inc. Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 150. Merck & Co., Inc. Product
Table 151. Merck & Co., Inc. Recent Development
Table 152. Johnson & Johnson Corporation Information
Table 153. Johnson & Johnson Description and Major Businesses
Table 154. Johnson & Johnson Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 155. Johnson & Johnson Product
Table 156. Johnson & Johnson Recent Development
Table 157. Biogen, Inc. Corporation Information
Table 158. Biogen, Inc. Description and Major Businesses
Table 159. Biogen, Inc. Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 160. Biogen, Inc. Product
Table 161. Biogen, Inc. Recent Development
Table 162. Takeda Corporation Information
Table 163. Takeda Description and Major Businesses
Table 164. Takeda Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 165. Takeda Product
Table 166. Takeda Recent Development
Table 167. Amgen, Inc. Corporation Information
Table 168. Amgen, Inc. Description and Major Businesses
Table 169. Amgen, Inc. Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 170. Amgen, Inc. Product
Table 171. Amgen, Inc. Recent Development
Table 172. Global Orphan Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 173. Global Orphan Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 174. Global Orphan Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 175. Global Orphan Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 176. North America: Orphan Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 177. North America: Orphan Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 178. Europe: Orphan Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 179. Europe: Orphan Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 180. Asia Pacific: Orphan Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 181. Asia Pacific: Orphan Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 182. Latin America: Orphan Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 183. Latin America: Orphan Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 184. Middle East and Africa: Orphan Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 185. Middle East and Africa: Orphan Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 186. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 187. Key Challenges
Table 188. Market Risks
Table 189. Main Points Interviewed from Key Orphan Drugs Players
Table 190. Orphan Drugs Customers List
Table 191. Orphan Drugs Distributors List
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Orphan Drugs Product Picture
Figure 2. Global Orphan Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oncology Product Picture
Figure 4. Gastrointestinal Product Picture
Figure 5. Pulmonary Product Picture
Figure 6. Neurology Product Picture
Figure 7. Hematology Product Picture
Figure 8. Cardio-vascular Product Picture
Figure 9. Metabolic disorders Product Picture
Figure 10. Endocrinology Product Picture
Figure 11. Infectious diseases Product Picture
Figure 12. Others Product Picture
Figure 13. Global Orphan Drugs Sales Market Share by Application in 2020 & 2026
Figure 14. Hospital Pharmacies
Figure 15. Speciality Pharmacies
Figure 16. Retail pharmacies
Figure 17. Others
Figure 18. Orphan Drugs Report Years Considered
Figure 19. Global Orphan Drugs Market Size 2015-2026 (US$ Million)
Figure 20. Global Orphan Drugs Sales 2015-2026 (K Units)
Figure 21. Global Orphan Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 22. Global Orphan Drugs Sales Market Share by Region (2015-2020)
Figure 23. Global Orphan Drugs Sales Market Share by Region in 2019
Figure 24. Global Orphan Drugs Revenue Market Share by Region (2015-2020)
Figure 25. Global Orphan Drugs Revenue Market Share by Region in 2019
Figure 26. Global Orphan Drugs Sales Share by Manufacturer in 2019
Figure 27. The Top 10 and 5 Players Market Share by Orphan Drugs Revenue in 2019
Figure 28. Orphan Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Orphan Drugs Sales Market Share by Type (2015-2020)
Figure 30. Global Orphan Drugs Sales Market Share by Type in 2019
Figure 31. Global Orphan Drugs Revenue Market Share by Type (2015-2020)
Figure 32. Global Orphan Drugs Revenue Market Share by Type in 2019
Figure 33. Global Orphan Drugs Market Share by Price Range (2015-2020)
Figure 34. Global Orphan Drugs Sales Market Share by Application (2015-2020)
Figure 35. Global Orphan Drugs Sales Market Share by Application in 2019
Figure 36. Global Orphan Drugs Revenue Market Share by Application (2015-2020)
Figure 37. Global Orphan Drugs Revenue Market Share by Application in 2019
Figure 38. North America Orphan Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 39. North America Orphan Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Orphan Drugs Sales Market Share by Country in 2019
Figure 41. North America Orphan Drugs Revenue Market Share by Country in 2019
Figure 42. U.S. Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. U.S. Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Canada Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. North America Orphan Drugs Market Share by Type in 2019
Figure 47. North America Orphan Drugs Market Share by Application in 2019
Figure 48. Europe Orphan Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 49. Europe Orphan Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Orphan Drugs Sales Market Share by Country in 2019
Figure 51. Europe Orphan Drugs Revenue Market Share by Country in 2019
Figure 52. Germany Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Germany Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. France Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. U.K. Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Italy Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Russia Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Europe Orphan Drugs Market Share by Type in 2019
Figure 63. Europe Orphan Drugs Market Share by Application in 2019
Figure 64. Asia Pacific Orphan Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 65. Asia Pacific Orphan Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Orphan Drugs Sales Market Share by Region in 2019
Figure 67. Asia Pacific Orphan Drugs Revenue Market Share by Region in 2019
Figure 68. China Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. China Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Japan Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. South Korea Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. India Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Australia Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Taiwan Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Indonesia Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Thailand Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 85. Malaysia Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Orphan Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 87. Philippines Orphan Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs